The EKG in the patient treated with calcium channel blockers
| Cardiology Network |
 Discuss The EKG in the patient treated with calcium channel blockers further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Electrocardiographic Findings
- In patients with sinus node disease, verapamil and diltiazem may cause severe bradycardia and even sinus arrest.
- Effect on rate depends on the balance between the effect on the conduction system and a reflex increase in the heart rate due to vasodilation.
- Diltiazem and verapamil may prolong the PR interval, nifedipine has no effect.
- No effect on the QRS or the QTc